Zur Rose Group AG
Zur Rose Group AG, headquartered in Switzerland (CH), is a leading player in the European healthcare and pharmaceutical industry. Founded in 1993, the company has established itself as a pioneer in online pharmacy services, primarily operating in Switzerland, Germany, and other key European markets. The group offers a diverse range of products and services, including prescription medications, over-the-counter drugs, and health-related products, all delivered through its innovative digital platforms. Zur Rose's commitment to customer-centric solutions and efficient logistics sets it apart in a competitive landscape. With a strong market position, Zur Rose Group AG has achieved significant milestones, including strategic partnerships and expansions that enhance its service offerings. The company continues to drive growth in the e-pharmacy sector, making healthcare more accessible to consumers across Europe.
DitchCarbon Score
How does Zur Rose Group AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zur Rose Group AG's score of 28 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zur Rose Group AG's reported carbon emissions
In 2023, Zur Rose Group AG reported total carbon emissions of approximately 1,494,500 kg CO2e, with emissions distributed across various scopes: 267,200 kg CO2e from Scope 1, 32,300 kg CO2e from Scope 2, and 1,195,000 kg CO2e from Scope 3. This reflects a continued commitment to transparency in their emissions reporting. Over the years, the company has shown fluctuations in its emissions. For instance, in 2022, total emissions were about 41,352,000 kg CO2e, with significant contributions from Scope 3 emissions. In 2021, emissions were approximately 3,969,000 kg CO2e, while in 2020, they reached about 3,903,000 kg CO2e. The data indicates a complex emissions profile, particularly with Scope 3 emissions, which often represent the largest share in many organisations. Zur Rose Group AG has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. This suggests that while the company is actively monitoring its emissions, it may not yet have formalised a comprehensive strategy for significant reductions in line with industry standards. Overall, Zur Rose Group AG's emissions data highlights the importance of ongoing assessment and potential future commitments to enhance their sustainability efforts in the healthcare and pharmaceutical sectors.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 773,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 3,130,000 | 0,000,000 | 0,000 | 00,000 |
| Scope 3 | 25,550,000 | 000,000 | 00,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zur Rose Group AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
